MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.

    H. Singh, D. Singhal, N. Sawal, A. Beri, S. Kumar, G. Hundal, A. Chawla (Chandigarh, India)

    Objective: To create a sensor controlled wearable system with an inflatable collar that offers protection against head, spine and shoulder girdle injuries in case of…
  • MDS Virtual Congress 2021

    To Prescribe or Not to Prescribe: The impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, K. Brittain, A. Bate, S. Dalkin, S. Mccarthy, R. Bradford, C. Allen, K. Mcdonald (Newcastle Upon Tyne, United Kingdom)

    Objective: After formal training, Parkinson’s Nurse Specialists (PNS) can act as independent and supplementary prescribers and initiate/titrate medication. This paper will discuss the impact of…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • MDS Virtual Congress 2021

    Challenges in Implementing Relevant Exercise Interventions in Mouse Models of Parkinson’s Disease

    D. Grogan, H. Skelton, J. Rubiano, C. Gutekunst, R. Gross (Augusta, USA)

    Objective: To determine the suitability of a motorized wheel as a forced exercise modality that does not rely on aversive stimuli for use in Parkinson’s…
  • MDS Virtual Congress 2021

    Perampanel inhibits α-synuclein transmission in Parkinson’s disease models

    J. Ueda, N. Uemura, R. Takahashi (Kyoto, Japan)

    Objective: To examine the effect of perampanel, an antiepileptic drug, on α-synuclein transmission in cultured cells and mouse models of Parkinson’s disease. Background: The intercellular transmission of pathogenic proteins…
  • MDS Virtual Congress 2021

    Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

    CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)

    Objective: To investigate the association between emotional/cognitive factors and the parameters of postural control of patients with Parkinson’s disease (PD) and freezing of gait (FoG).…
  • MDS Virtual Congress 2021

    Cognitive Diagnostics for Parkinson’s Disease: A Novel Digitized Approach Using Non-Motor Symptoms

    A. Murrar, M. Abu Snineh, M. Herzallah (Jerusalemp, State of Palestine)

    Objective: To evaluate the validity and reliability of cognitive markers to identify patients with PD Background: Parkinson’s disease (PD) is classically diagnosed by the clinical…
  • MDS Virtual Congress 2021

    THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

    S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

    Objective: This study aims to evaluate the effect of using masks on face recognition ability in Patients with Parkinson’s disease (PwP). Background: Patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Parkin Mutation and Deep Brain Stimulation

    E. Erdil, H. Omercikoglu, F. Bayraklı, D. Gunal (Istanbul, Turkey)

    Objective: To investigate the clinical features of Parkin mutated patients who undergone subthalamic brain stimulation (DBS group) and pharmalogically treated only (Non-DBS group). Background: The…
  • MDS Virtual Congress 2021

    Nanopore single-molecule sequencing to investigate mitochondrial DNA CpG methylation in Parkinson’s disease

    T. Lüth, K. Wasner, C. Klein, S. Schaake, R. Tse, S. Pereira, J. Laß, L. Sinkkonen, A. Grünewald, J. Trinh (Lübeck, Germany)

    Objective: Nanopore whole-genome sequencing of native DNA to investigate mitochondrial DNA (mtDNA) CpG methylation from patients with Parkinson’s disease (PD) and healthy controls. Background: PD…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley